LSH-BIOTECH ApS
CVR number: 30827538
Emilsvej 32, 8600 Silkeborg
cdr@lsh-biotech.dk
tel: 29603008
Income statement (kDKK)
| 2016 | 2017 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 1 528.48 | 954.08 | 773.75 | 721.17 | 1 179.23 |
| Employee benefit expenses | - 338.86 | - 331.94 | - 303.61 | - 308.93 | - 307.96 |
| Total depreciation | -69.75 | -69.75 | -40.19 | -8.70 | |
| EBIT | 1 119.87 | 552.39 | 429.95 | 403.53 | 871.27 |
| Other financial income | 0.37 | ||||
| Other financial expenses | -6.51 | -8.74 | -7.46 | -21.83 | -6.84 |
| Pre-tax profit | 1 113.36 | 543.65 | 422.49 | 381.71 | 864.80 |
| Income taxes | - 252.14 | - 134.63 | -79.58 | -87.82 | - 191.05 |
| Net earnings | 861.22 | 409.02 | 342.91 | 293.88 | 673.75 |
Assets (kDKK)
| 2016 | 2017 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Machinery and equipment | 118.64 | 48.89 | 8.70 | ||
| Tangible assets total | 118.64 | 48.89 | 8.70 | ||
| Investments total | |||||
| Long term receivables total | |||||
| Raw materials and consumables | 23.98 | 20.00 | |||
| Inventories total | 23.98 | 20.00 | |||
| Current trade debtors | 291.74 | 270.06 | 46.31 | 175.37 | 520.71 |
| Current amounts owed by group member comp. | 145.00 | 798.60 | |||
| Current other receivables | 1.11 | 56.87 | |||
| Current deferred tax assets | 13.77 | 50.87 | 50.87 | ||
| Short term receivables total | 291.74 | 270.06 | 60.08 | 372.35 | 1 427.05 |
| Cash and bank deposits | 1 765.91 | 1 004.17 | 1 530.33 | 6.88 | 130.26 |
| Cash and cash equivalents | 1 765.91 | 1 004.17 | 1 530.33 | 6.88 | 130.26 |
| Balance sheet total (assets) | 2 176.29 | 1 323.12 | 1 599.11 | 403.21 | 1 577.31 |
Equity and liabilities (kDKK)
| 2016 | 2017 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|---|
| Share capital | 125.00 | 125.00 | 125.00 | 125.00 | 125.00 |
| Shares repurchased | 1 000.00 | 400.00 | 611.73 | 700.00 | |
| Retained earnings | - 601.42 | - 140.20 | - 342.91 | - 229.17 | - 635.29 |
| Profit of the financial year | 861.22 | 409.02 | 342.91 | 293.88 | 673.75 |
| Shareholders equity total | 1 384.80 | 793.82 | 736.73 | 189.71 | 863.47 |
| Non-current deferred tax liabilities | 74.05 | 191.05 | |||
| Non-current liabilities total | 74.05 | 191.05 | |||
| Current loans from credit institutions | 18.50 | ||||
| Current trade creditors | 76.82 | 77.51 | 107.30 | 10.00 | 213.35 |
| Current owed to participating | 0.63 | 2.69 | 6.02 | ||
| Current owed to group member | 400.00 | ||||
| Short-term deferred tax liabilities | 387.20 | 363.03 | 154.89 | ||
| Other non-interest bearing current liabilities | 327.47 | 88.78 | 199.56 | 108.26 | 303.42 |
| Current liabilities total | 791.49 | 529.31 | 862.38 | 139.45 | 522.79 |
| Balance sheet total (liabilities) | 2 176.29 | 1 323.12 | 1 599.11 | 403.21 | 1 577.31 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.